PlainRecalls

Novartis Pharmaceuticals Corporation

7 recalls on record · Latest: Aug 19, 2026

Subscribe to new Novartis Pharmaceuticals Co… recalls (RSS)

Agency notice ledger

Federal filing book Novartis Pharmaceuticals Co… LIGHT-BOOK · SINGLE-AGENCY

#1,990 of 14,151 · 7 notices · 0.007% archive

  • BOOK 7 notices
  • RANK #1,990 of 14,151
  • SHARE 0.007% archive
  • AGENCY FDA Drug (7)
  • CAT drugs
  • CATS 1 category
  • LATEST Aug 19, 2026
  • PHOTO A I Foods Corporation

Nearest notice-volume peer: A I Foods Corporation (0 notice gap)

Novartis Pharmaceuticals Corporation accounts for about 0.007% of the 104,423-notice archive on 7 distinct filings — a mid share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

Novartis Pharmaceuticals Co…'s standing among 14,151 recalling firms

Novartis Pharmaceuticals Corporation ranks 1,990th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Novartis Pharmaceuticals Co… vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

7 1990th of 14151 higher than 12,091 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-13

Novartis Pharmaceuticals Co… in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Novartis Pharmaceuticals Corporation holds about 0.007% of archive notices alongside 7 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Moderate Aug 19, 2026

Diovan (valsartan) 160 mg, 90 tablets, Rx only, Manufactured by: Patheon Manufacturing Services LLC, Greenville, NC 27834, Distributed by: Novartis Pharmaceutical Corp, East Hanover, NJ 07936, NDC 0078-0359-34

FDA Drug Critical Dec 13, 2023

SANDIMMUNE Oral Solution (cyclosporine oral solution, USP) 100 mg/mL, 50 mL bottle, Rx Only, Manufactured by: DELPHARM Huningue S.A.S., Huningue, France, Distributed by: Novartis Pharmaceuticals Corporation, East Hanover, New Jersey 07936. NDC 0078-0110-22

FDA Drug Moderate Oct 5, 2022

Neoral soft gelatin capsules (cyclosporine capsules, USP) Modified, 25 mg, Rx Only, 30 Soft Gelatin Capsules per carton, Mfg by: Novartis Pharmaceuticals Corporation, East Hanover, NJ 07936, NDC # 0078-0246-15.

FDA Drug Low Jun 15, 2022

Xiidra (lifitegrast ophthalmic solution) 5% PROFESSIONAL SAMPLE, packaged in a) 5 single-use containers (0.2 mL each vial) (NDC 54092-606-07) and b) 4 pouches x 5 single-use containers (NDC 54092-606-04), Rx Only, Manufactured for: Shire US Inc., 300 Shire Way, Lexington, MA 02421.

FDA Drug Low Jun 15, 2022

Xiidra (lifitegrast ophthalmic solution) 5% PROFESSIONAL SAMPLE, packaged in a) 5 single-use containers (0.2 mL each vial) (NDC 0078-0911-95) and b) 4 pouches x 5 single-use containers (NDC 0078-0911-94), Rx Only, Manufactured by: The Ritedose Corporation Columbia, SC 29203; Distributed by: Novartis Pharmaceuticals Corporation East Hanover, NJ 07936.

FDA Drug Low Jun 15, 2022

Xiidra (lifitegrast ophthalmic solution) 5%, packaged in a) 60 Single-Use Containers: 12 pouches x 5 single-use containers (0.2 mL each vial) (NDC 54092-606-01) and b) 5-Single-Use Containers (NDC 54092-606-06), Rx Only, Manufactured for: Shire US Inc., 300 Shire Way, Lexington, MA 02421.

FDA Drug Low Jun 15, 2022

Xiidra (lifitegrast ophthalmic solution), packaged in a) 60 Single-Use Containers: 12 pouches x 5 single-use containers (0.2 mL each vial) (NDC 0078-0911-12) and b) 5- Single-Use Containers (NDC 0078-0911-05) Rx Only, Manufactured by: The Ritedose Corporation, Columbia, SC 29203, Distributed by: Novartis Pharmaceuticals Corporation, East Hanover, NJ 07936.

Novartis Pharmaceuticals Co… holds a measurable archive slice

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Frequently Asked Questions

How many federal recall notices name Novartis Pharmaceuticals Co…?
PlainRecalls indexes 7 distinct federal recall events naming Novartis Pharmaceuticals Corporation, aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Novartis Pharmaceuticals Co… sit among other recalling firms?
Novartis Pharmaceuticals Corporation ranks #1,990 of 14,151 by distinct recall-event count among 14,151 firms in this archive (85th percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Novartis Pharmaceuticals Co…'s notices?
FDA Drug accounts for 7 of this firm's 7 indexed notices.
What product category dominates Novartis Pharmaceuticals Co…'s filing book?
Filings for Novartis Pharmaceuticals Corporation span 1 product category, led by drugs. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous?
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Novartis Pharmaceuticals Corporation: 7 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Novartis Pharmaceuticals Corporation; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026